FDA Issues Concern over Experimental Procedures Using Angioplasty to Treat Autonomic Dysfunction

On 3/28/17,  the FDA issued a press release about an experimental procedure called Transvascular Autonomic Modulation (TVAM). Click to read the release.

Read More